StockData
Erasca, Inc. logo

Erasca, Inc. (ERAS) stock

ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$13.89−1.22 (-8.07%)

Close on Nov 17, 2026Market cap $4.86BP/E –Yield 0.00%

Erasca operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Erasca's operating cash flow for the twelve months ending Jun 30, 2026 was -$98.02M. For fiscal 2025 it was -$95.46M. The highest annual figure on record is -$32.69M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$95.46M–
FY2024Dec 31, 2024-$109.42M–
FY2023Dec 31, 2023-$101.22M–
FY2022Dec 31, 2022-$103.26M–
FY2021Dec 31, 2021-$79.60M–
FY2020Dec 31, 2020-$32.69M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$27.27M–
Q1 FY2026Mar 31, 2026-$27.38M–
Q4 FY2025Dec 31, 2025-$21.71M–
Q3 FY2025Sep 30, 2025-$21.66M–
Q2 FY2025Jun 30, 2025-$20.53M–
Q1 FY2025Mar 31, 2025-$31.56M–
Q4 FY2024Dec 31, 2024-$24.56M–
Q3 FY2024Sep 30, 2024-$22.42M–
Q2 FY2024Jun 30, 2024-$29.18M–
Q1 FY2024Mar 31, 2024-$33.25M–
Q4 FY2023Dec 31, 2023-$24.79M–
Q3 FY2023Sep 30, 2023-$24.12M–
Q2 FY2023Jun 30, 2023-$25.95M–
Q1 FY2023Mar 31, 2023-$26.36M–
Q4 FY2022Dec 31, 2022-$26.37M–
Q3 FY2022Sep 30, 2022-$23.95M–
Q2 FY2022Jun 30, 2022-$27.14M–
Q1 FY2022Mar 31, 2022-$25.81M–
Q4 FY2021Dec 31, 2021-$22.48M–
Q3 FY2021Sep 30, 2021-$23.22M–
Q2 FY2021Jun 30, 2021-$18.23M–
Q1 FY2021Mar 31, 2021-$15.67M–
Q4 FY2020Dec 31, 2020-$13.10M–
Q3 FY2020Sep 30, 2020-$7.48M–

More Erasca figures

See a number that looks wrong?